Olivier Lamy

Publications | Phd and Masters theses

Advanced search is available through Serval

Publications can be managed by accessing Serval via MyUnil


293 publications

In press | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | ...
 
Diurnal Salivary Cortisol in Sarcopenic Postmenopausal Women: The OsteoLaus Cohort.
Gonzalez Rodriguez E., Marques-Vidal P., Aubry-Rozier B., Papadakis G., Preisig M., Kuehner C., Vollenweider P., Waeber G., Hans D., Lamy O. Calcified tissue international. Peer-reviewed.
 
Vers un rapport de santé osseuse individualisé centré sur le patient - Les paramètres osseux et les possibilités de traite [Towards an individualized bone health report focused on the patient - Bone parameters and treatment options]
Shevroja E., Lamy O., Gonzalez Rodriguez E., Hans D., 2021/04/21. Revue medicale suisse, 17 (735) pp. 774-779. Peer-reviewed.
Hypercalcemia upon denosumab withdrawal in primary hyperparathyroidism: a case report and literature review.
Camponovo C., Aubry-Rozier B., Lamy O., Gonzalez Rodriguez E., 2020/12. Osteoporosis international, 31 (12) pp. 2485-2491. Peer-reviewed.
Commentary to "Denosumab for bone health in prostate and breast cancer patients receiving endocrine therapy? A systematic review and a meta-analysis of randomized trials" (Galvano et al. J Bone Oncol 2019; 18:100252).
Gonzalez-Rodriguez E., Aubry-Rozier B., Stoll D., Zaman K., Lamy O., 2020/06. Journal of bone oncology, 22 p. 100294. Peer-reviewed.
 
Unknown osteoporosis in older patients admitted to post-acute rehabilitation.
Major K., Monod S., Bula C.J., Krief H., Hans D., Lamy O., Krieg M.A., 2020/06. Aging clinical and experimental research, 32 (6) pp. 1145-1152. Peer-reviewed.
 
Increased Risk of Multiple Spontaneous Vertebral Fractures at Denosumab Discontinuation Must Be Taken Into Account.
Gonzalez-Rodriguez E., Aubry-Rozier B., Stoll D., Zaman K., Lamy O., 2020/05/10. Journal of clinical oncology, 38 (14) pp. 1641-1642. Peer-reviewed.
Postmenopausal women with osteoporosis consume high amounts of vegetables but insufficient dairy products and calcium to benefit from their virtues: the CoLaus/OsteoLaus cohort.
Lanyan A., Marques-Vidal P., Gonzalez-Rodriguez E., Hans D., Lamy O., 2020/05. Osteoporosis international, 31 (5) pp. 875-886. Peer-reviewed.
 
Impacts organisationnels et défis cliniques de la pandémie COVID-19 pour un service hospitalier de médecine interne universitaire [Organizational Impacts and Clinical Challenges of the COVID-19 Pandemic on a Swiss Tertiary Internal Medicine Department]
Garnier A., Vaucher J., Bianchi C., Kraege V., Méan M., Castioni J., Bart P.A., Champier V., Eggimann P., Gachoud D. et al., 2020/04/29. Revue medicale suisse, 16 (N° 691-2) pp. 869-874. Peer-reviewed.
“Inflammaging” and bone in the OsteoLaus cohort
Fischer Jessica, Hans Didier, Lamy Olivier, Marques-Vidal Pedro, Vollenweider Peter, Aubry-Rozier Bérengère, 2020/03. Immunity & Ageing, 17 (1). Peer-reviewed.
Association Between Physical Activity Levels in the Hospital Setting and Hospital-Acquired Functional Decline in Elderly Patients.
Tasheva P., Vollenweider P., Kraege V., Roulet G., Lamy O., Marques-Vidal P., Méan M., 2020/01/03. JAMA network open, 3 (1) pp. e1920185. Peer-reviewed.
 
OsteoLaus: raisons d’être et premiers résultats []
Shevroja E., Hans D., Aubry-Rozier B., Gonzalez-Rodriguez E., Lamy O., 2020/01. Praxis, 109 (1) pp. 19-22. Peer-reviewed.
 
Sixty spontaneous vertebral fractures after denosumab discontinuation in 15 women with early-stage breast cancer under aromatase inhibitors.
Gonzalez-Rodriguez E., Aubry-Rozier B., Stoll D., Zaman K., Lamy O., 2020/01. Breast cancer research and treatment, 179 (1) pp. 153-159. Peer-reviewed.
 
Vertebral Fractures in Individuals With Type 2 Diabetes: More Than Skeletal Complications Alone.
Koromani F., Oei L., Shevroja E., Trajanoska K., Schoufour J., Muka T., Franco O.H., Ikram M.A., Zillikens M.C., Uitterlinden A.G. et al., 2020/01. Diabetes care, 43 (1) pp. 137-144. Peer-reviewed.
 
Clinical Performance of the Updated Trabecular Bone Score (TBS) Algorithm, Which Accounts for the Soft Tissue Thickness: The OsteoLaus Study.
Shevroja E., Aubry-Rozier B., Hans G., Rodriguez E.G., Stoll D., Lamy O., Hans D., 2019/12. Journal of bone and mineral research, 34 (12) pp. 2229-2237. Peer-reviewed.
Meningitis due to non-steroidal anti-inflammatory drugs: an often-overlooked complication of a widely used medication.
Desgranges F., Tebib N., Lamy O., Kritikos A., 2019/11/07. BMJ case reports, 12 (11). Peer-reviewed.
 
Vertébroplastie chez les patients âgés : is less still too much ? [Vertebroplasty in elderly patients : is less still too much ?]
Félix S., Humbert M., Büla C., Lamy O., 2019/11/06. Revue medicale suisse, 15 (670) pp. 2027-2031. Peer-reviewed.
 
Bisphosphonates as a First-Line Treatment for Glucocorticoid-Induced Osteoporosis: Comment on the Article by Saag et al.
Gonzalez-Rodriguez E., Aubry-Rozier B., Stoll D., Lamy O., 2019/10. Arthritis & rheumatology, 71 (10) pp. 1770-1771. Peer-reviewed.
 
The Metabolic Benefits of Menopausal Hormone Therapy Are Not Mediated by Improved Nutritional Habits. The OsteoLaus Cohort.
Papadakis G.E., Hans D., Gonzalez Rodriguez E., Vollenweider P., Waeber G., Marques-Vidal P., Lamy O., 2019/08/16. Nutrients, 11 (8). Peer-reviewed.
 
A potential role of hypophosphatemia for diagnosing convulsive seizures: A case-control study.
Barras P., Siclari F., Hügli O., Rossetti A.O., Lamy O., Novy J., 2019/08. Epilepsia, 60 (8) pp. 1580-1585. Peer-reviewed.
 
Cohort Profile: The OsteoLaus study.
Shevroja E., Marques-Vidal P., Aubry-Rozier B., Hans G., Rivadeneira F., Lamy O., Hans D., 2019/08/01. International journal of epidemiology, 48 (4) pp. 1046-1047g. Peer-reviewed.
 
Letter to the Editor: "Pharmacological Management of Osteoporosis in Postmenopausal Women: An Endocrine Society Clinical Practice Guideline".
Gonzalez Rodriguez E., Lamy O., 2019/08/01. The Journal of clinical endocrinology and metabolism, 104 (8) pp. 3535-3536. Peer-reviewed.
 
Impact of increased preparation time for residents before ward rounds: the MED2DAY Study
Gachoud David, Monti Matteo, Marques Vidal Pedro, Castioni Julien, Mean Marie, Lamy Olivier, Bastardot Francois, Wenger Nathalie, Vollenweider Peter, Waeber Gérard et al., 2019/05/05., Société Suisse de Médecine Interne Générale dans Primary and Hospital Care, EMH Editions médicales suisses SA.
 
Alendronate after denosumab discontinuation in women previously exposed to bisphosphonates was not effective in preventing the risk of spontaneous multiple vertebral fractures: two case reports.
Lamy O., Fernández-Fernández E., Monjo-Henry I., Stoll D., Aubry-Rozier B., Benavent-Núñez D., Aguado P., Gonzalez-Rodriguez E., 2019/05. Osteoporosis international, 30 (5) pp. 1111-1115. Peer-reviewed.
 
Denosumab in early-stage breast cancer.
Gonzalez Rodriguez E., Aubry-Rozier B., Stoll D., Lamy O., 2019/05. The Lancet. Oncology, 20 (5) pp. e233. Peer-reviewed.
 
Diagnosis, prevention, and treatment of bone fragility in people living with HIV: a position statement from the Swiss Association against Osteoporosis.
Biver E., Calmy A., Aubry-Rozier B., Birkhäuser M., Bischoff-Ferrari H.A., Ferrari S., Frey D., Kressig R.W., Lamy O., Lippuner K. et al., 2019/05. Osteoporosis international, 30 (5) pp. 1125-1135. Peer-reviewed.
Swiss Recommendations for Adult Cystic Fibrosis Care: Bone disease
Koutsokera Angela, Lamy Olivier, Challet Corinne, Hofer Markus, Schmid Christoph, 2019/05/01. dans Swiss Recommendations for Adult Cystic Fibrosis Care, RMS Editions/Médecine et Hygiène.
 
Comment gérer l’effet rebond à l’arrêt du dénosumab et éviter les fractures vertébrales multiples ? [How to manage the rebound effect at denosumab discontinuation and avoid multiple vertebral fractures?]
Gonzalez Rodriguez E., Lamy O., Aubry-Rozier B., Stoll D., Uebelhart B., 2019/04/17. Revue medicale suisse, 15 (647) pp. 831-835. Peer-reviewed.
 
Ostéoporose : une urgence []
Lamy O., Uebelhart B., 2019/04/17. Revue medicale suisse, 15 (647) pp. 807-808. Peer-reviewed.
 
Patients à risque imminent de fractures : quelles conséquences pour la prise en charge ? [Patients with imminent fracture risk : which consequences for their management ?]
Uebelhart B., Lamy O., 2019/04/17. Revue medicale suisse, 15 (647) pp. 821-823. Peer-reviewed.
 
Traitement hormonal de la ménopause : effets osseux et sur la composition corporelle [Menopausal hormone therapy. Effects on bone and body composition]
Papadakis G., Gonzalez Rodriguez E., Marques-Vidal P., Hans D., Vollenweider P., Waeber G., Lamy O., 2019/04/17. Revue medicale suisse, 15 (647) pp. 836-839. Peer-reviewed.
 
Stopping Denosumab.
Lamy O., Stoll D., Aubry-Rozier B., Rodriguez E.G., 2019/02. Current osteoporosis reports, 17 (1) pp. 8-15. Peer-reviewed.
 
L’année 2018 mise en perspective par les internistes hospitaliers [The internal medicine articles that struck us the most in 2018]
Kraege V., Aebischer O., Chocron Y., Bongard C., Moulin V., Schneider A., Humair G., Solimando É., Lu H., Lamy O., 2019/01/09. Revue medicale suisse, 15 (634) pp. 146-148. Peer-reviewed.
 
Spontaneous Vertebral Fractures in Males with Osteoporosis After Denosumab Discontinuation: A Report of Two Cases.
Anagnostis P., Paschou S.A., Gonzalez-Rodriguez E., Potoupnis M., Tsiridis E., Lamy O., Goulis D.G., 2019/01/04. Journal of clinical rheumatology. Peer-reviewed.
 
Response to Letter to the Editor: "Menopausal Hormone Therapy Is Associated With Reduced and Total Visceral Adiposity: The OsteoLaus Cohort".
Papadakis G.E., Lamy O., 2018/11/01. The Journal of clinical endocrinology and metabolism, 103 (11) pp. 4035-4036. Peer-reviewed.
Effectiveness of a transition plan at discharge of patients hospitalized with heart failure: a before-and-after study.
Garnier A., Rouiller N., Gachoud D., Nachar C., Voirol P., Griesser A.C., Uhlmann M., Waeber G., Lamy O., 2018/08. ESC heart failure, 5 (4) pp. 657-667. Peer-reviewed.
 
Fractures vertébrales multiples à l’arrêt du denosumab: comment les éviter? [Multiple Vertebral Fractures after Denosumab Discontinuation: How to Avoid Them?]
Lamy O., Gonzalez Rodriguez E., Stoll D., Aubry-Rozier B., Livio F., 2018/06. Praxis, 107 (12) pp. 649-654. Peer-reviewed.
Menopausal Hormone Therapy Is Associated With Reduced Total and Visceral Adiposity: The OsteoLaus Cohort.
Papadakis G.E., Hans D., Rodriguez E.G., Vollenweider P., Waeber G., Marques-Vidal P., Lamy O., 2018/05/01. The Journal of clinical endocrinology and metabolism, 103 (5) pp. 1948-1957. Peer-reviewed.
 
Underestimation of Vertebral Fractures After Denosumab Discontinuation.
Lamy O., Gonzalez-Rodriguez E., 2018/03. Journal of bone and mineral research, 33 (3) p. 547. Peer-reviewed.
Correlation study between osteoporosis and hematopoiesis in the context of adjuvant chemotherapy for breast cancer.
Schyrr F., Wolfer A., Pasquier J., Nicoulaz A.L., Lamy O., Naveiras O., 2018/02. Annals of hematology, 97 (2) pp. 309-317. Peer-reviewed.
 
Medication reconciliation in a Swiss hospital: methods, benefits and pitfalls.
Nachar C., Lamy O., Sadeghipour F., Garnier A., Voirol P., 2018/01/30. European journal of hospital pharmacy, 26 (3) pp. 129-134. Peer-reviewed.
 
Quand le service déborde : impact de la satellisation des patients sur leur prise en charge [When the ward overflows : the impact of outlying beds on patient care]
Mosimann V., Lamy O., Castioni J., 2018/01/17. Revue medicale suisse, 14 (590) pp. 150-153. Peer-reviewed.
Impact of a fracture liaison service on patient management after an osteoporotic fracture: the CHUV FLS.
Aubry-Rozier B., Stoll D., Gonzalez Rodriguez E., Hans D., Prudent V., Seuret A., Farron A., Lamy O., 2018. Swiss medical weekly, 148 pp. w14579. Peer-reviewed.
Raloxifene Has No Efficacy in Reducing the High Bone Turnover and the Risk of Spontaneous Vertebral Fractures after Denosumab Discontinuation.
Gonzalez-Rodriguez E., Stoll D., Lamy O., 2018. Case reports in rheumatology, 2018 p. 5432751. Peer-reviewed.
Review on the Utility of Trabecular Bone Score, a Surrogate of Bone Micro-architecture, in the Chronic Kidney Disease Spectrum and in Kidney Transplant Recipients.
Shevroja E., Lamy O., Hans D., 2018. Frontiers in endocrinology, 9 p. 561. Peer-reviewed.
 
Treatment of Low Bone Density or Osteoporosis to Prevent Fractures in Men and Women.
Lamy O., Aubry-Rozier B., Gonzalez-Rodriguez E., 2017/12/19. Annals of internal medicine, 167 (12) pp. 900-901. Peer-reviewed.
 
The Trabecular Bone Score (TBS) Complements DXA and the FRAX as a Fracture Risk Assessment Tool in Routine Clinical Practice.
Hans D., Šteňová E., Lamy O., 2017/12. Current osteoporosis reports, 15 (6) pp. 521-531. Peer-reviewed.
Osteoporosis drug treatment: duration and management after discontinuation. A position statement from the SVGO/ASCO.
Meier C., Uebelhart B., Aubry-Rozier B., Birkhäuser M., Bischoff-Ferrari H.A., Frey D., Kressig R.W., Lamy O., Lippuner K., Stute P. et al., 2017/09/05. Swiss medical weekly, 147 pp. w14484. Peer-reviewed.
Prediction of potentially avoidable readmission risk in a division of general internal medicine.
Uhlmann M., Lécureux E., Griesser A.C., Duong H.D., Lamy O., 2017/07/27. Swiss medical weekly, 147 pp. w14470. Peer-reviewed.
 
High Evening Cortisol Level Is Associated With Low TBS and Increased Prevalent Vertebral Fractures: OsteoLaus Study.
Gonzalez Rodriguez E., Lamy O., Stoll D., Metzger M., Preisig M., Kuehner C., Vollenweider P., Marques-Vidal P., Waeber G., Aubry-Rozier B. et al., 2017/07/01. The Journal of clinical endocrinology and metabolism, 102 (7) pp. 2628-2636. Peer-reviewed.
 
Clinical Features of 24 Patients With Rebound-Associated Vertebral Fractures After Denosumab Discontinuation: Systematic Review and Additional Cases.
Anastasilakis A.D., Polyzos S.A., Makras P., Aubry-Rozier B., Kaouri S., Lamy O., 2017/06. Journal of bone and mineral research, 32 (6) pp. 1291-1296. Peer-reviewed.
 
Response to Letter: Severe Rebound-Associated Vertebral Fractures After Denosumab Discontinuation.
Lamy O., Gonzalez-Rodriguez E., Aubry-Rozier B., 2017/06/01. The Journal of clinical endocrinology and metabolism, 102 (6) p. 2112. Peer-reviewed.
 
Dénosumab en routine clinique: précautions à prendre avant, pendant et après [Denosumab in clinical practice : beware before, during and after]
Lamy O., Gonzalez-Rodriguez E., Stoll D., Aubry-Rozier B., 2017/04/19. Revue medicale suisse, 13 (559) pp. 863-866. Peer-reviewed.
 
Les métamorphoses du traitement de l’ostéoporose
Ferrari S., Lamy O., 2017/04/19. Revue medicale suisse, 13 (559) pp. 835-836. Peer-reviewed.
 
Trabecular Bone Score en complément à l’absorptiométrie radiologique biphotonique dans l’évaluation du risque fracturaire en routine clinique [Use of Trabecular Bone Score as a complementary approach to DXA for fracture risk assessment in clinical practice]
Hans D., Shevroja E., Lamy O., 2017/04/19. Revue medicale suisse, 13 (559) pp. 844-850. Peer-reviewed.
 
Response to the Letter by Trovas.
Lamy O., Gonzalez-Rodriguez E., Aubry-Rozier B., 2017/04/01. The Journal of clinical endocrinology and metabolism, 102 (3) p. 1087. Peer-reviewed.
 
The lumbar spine age-related degenerative disease influences the BMD not the TBS: the Osteolaus cohort.
Padlina I., Gonzalez-Rodriguez E., Hans D., Metzger M., Stoll D., Aubry-Rozier B., Lamy O., 2017/03. Osteoporosis international, 28 (3) pp. 909-915. Peer-reviewed.
 
Impact of level of expertise versus the statistical tool on vertebral fracture assessment (VFA) readings in cohort studies.
Aubry-Rozier B., Fabreguet I., Iglesias K., Lamy O., Hans D., 2017/02. Osteoporosis international, 28 (2) pp. 523-527. Peer-reviewed.
 
L’année 2016 mise en perspective par les internistes hospitaliers [What is new in 2016 for the specialist in hospital internal medicine?]
Mraihi H., Chevaux F., Castoni J., Aebischer O., Christou F., Jaccard E., Benmachiche M., Tasheva P., Giroud S., Kraege V. et al., 2017/01/18. Revue medicale suisse, 13 (546) pp. 138-141. Peer-reviewed.
 
The added value of trabecular bone score to FRAX® to predict major osteoporotic fractures for clinical use in Chinese older people: the Mr. OS and Ms. OS cohort study in Hong Kong.
Su Y., Leung J., Hans D., Lamy O., Kwok T., 2017/01. Osteoporosis international, 28 (1) pp. 111-117. Peer-reviewed.
 
Use of Trabecular Bone Score (TBS) as a Complementary Approach to Dual-energy X-ray Absorptiometry (DXA) for Fracture Risk Assessment in Clinical Practice.
Shevroja E., Lamy O., Kohlmeier L., Koromani F., Rivadeneira F., Hans D., 2017. Journal of clinical densitometry, 20 (3) pp. 334-345. Peer-reviewed.
The Benefit of Menopausal Hormone Therapy on Bone Density and Microarchitecture Persists After its Withdrawal.
Papadakis G., Hans D., Gonzalez-Rodriguez E., Vollenweider P., Waeber G., Marques-Vidal P.M., Lamy O., 2016/12. The Journal of clinical endocrinology and metabolism, 101 (12) pp. 5004-5011. Peer-reviewed.
 
Ostéoporose chez les femmes ménopausées entre 40 et 65 ans : algorithme pour le gynécologue [Osteoporosis in menopausal women between 40 and 65 years old : an algorithm for the gynaecologist]
Surbone A., Vulliemoz N., Gonzalez-Rodriguez E., Chatelain J.P., Lamy O., 2016/10/26. Revue medicale suisse, 12 (536) pp. 1811-1815. Peer-reviewed.
 
Romosozumab Treatment in Postmenopausal Women with Osteoporosis.
Cosman F., Crittenden D.B., Adachi J.D., Binkley N., Czerwinski E., Ferrari S., Hofbauer L.C., Lau E., Lewiecki E.M., Miyauchi A. et al., 2016/10/20. The New England journal of medicine, 375 (16) pp. 1532-1543. Peer-reviewed.
 
Severe rebound-associated vertebral fractures after denosumab discontinuation: nine clinical cases report.
Lamy O., Gonzalez-Rodriguez E., Stoll D., Hans D., Aubry-Rozier B., 2016/10/12. The Journal of clinical endocrinology and metabolism, 102 (2) pp. 354-358. Peer-reviewed.
 
A Meta-Analysis of Trabecular Bone Score in Fracture Risk Prediction and Its Relationship to FRAX.
McCloskey E.V., Odén A., Harvey N.C., Leslie W.D., Hans D., Johansson H., Barkmann R., Boutroy S., Brown J., Chapurlat R. et al., 2016/05. Journal of bone and mineral research, 31 (5) pp. 940-948. Peer-reviewed.
 
Severe spontaneous vertebral fractures after denosumab discontinuation: three case reports.
Aubry-Rozier B., Gonzalez-Rodriguez E., Stoll D., Lamy O., 2016/05. Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA, 27 (5) pp. 1923-1925. Peer-reviewed.
Predictors and Implications of Early Clinical Stability in Patients Hospitalized for Moderately Severe Community-Acquired Pneumonia.
Garin N., Felix G., Chuard C., Genné D., Carballo S., Hugli O., Lamy O., Marti C., Nendaz M., Rutschmann O. et al., 2016. PloS one, 11 (6) pp. e0157350. Peer-reviewed.
 
Trabecular bone score in type 1 diabetes--a cross-sectional study.
Neumann T., Lodes S., Kästner B., Lehmann T., Hans D., Lamy O., Müller U.A., Wolf G., Sämann A., 2016. Osteoporosis International : A Journal Established As Result of Cooperation Between the European Foundation For Osteoporosis and the National Osteoporosis Foundation of the Usa, 27 (1) pp. 127-133. Peer-reviewed.
 
Au sortir de l'hôpital, comment renforcer la continuité de la prise en charge médicale [Discharge from hospital: how to improve continuity of medical care?].
Garnier A., Uhlmann M., Griesser A.C., Lamy O., 2015/11. Revue Médicale Suisse, 11 (493) pp. 2064, 2066-2064, 2069.
 
Accélération de la guérison fracturaire par le tériparatide: série de 22 cas et revue de la littérature [Improvement of fracture healing with teriparatide: series of 22 cases and review of the literature].
Lecoultre J., Stoll D., Chevalley F., Lamy O., 2015. Revue Médicale Suisse, 11 (466) pp. 663-667.
 
Imagerie par DXA: le couteau suisse multifonction [DXA imaging: the multifunction Swiss army knife?].
Gonzalez Rodriguez E., Favre L., Lamy O., Pralong F., Hans D., 2015. Revue Médicale Suisse, 11 (466) pp. 645-650. Peer-reviewed.
 
Pancytopénie avec anémie hémolytique et schizocytes: une approche pragmatique [Pancytopenia, Hemolytic Anemia and Schizocytes: a Pragmatic Approach].
Gökok N., Stalder G., Alberio L., Lamy O., Schwotzer N., 2015. Praxis, 104 (14) pp. 751-754. Peer-reviewed.
 
Reproducibility of Vertebral Fracture Assessment Readings From Dual-energy X-ray Absorptiometry in Both a Population-based and Clinical Cohort: Cohen's and Uniform Kappa.
Aubry-Rozier B., Chapurlat R., Duboeuf F., Iglesias K., Krieg M.A., Lamy O., Burnand B., Hans D., 2015. Journal of Clinical Densitometry, 18 (2) pp. 233-238. Peer-reviewed.
Trabecular bone score (TBS) as a new complementary approach for osteoporosis evaluation in clinical practice.
Harvey N.C., Glüer C.C., Binkley N., McCloskey E.V., Brandi M.L., Cooper C., Kendler D., Lamy O., Laslop A., Camargos B.M. et al., 2015. Bone, 78 pp. 216-224. Peer-reviewed.
 
Health care professional's' attitudes towards bedside case presentations during ward rounds
Gachoud D., Garnier A., Monti M., Bart P.-A., Lamy O., Marques-Vidal P., Vollenweider P., Sartori C., Bonvin R., Villar B. et al., 2014/05. dans European and Swiss congress of Internal Medicine 2014.
Potentially avoidable readmissions: it worth to improve discharge summary delivery delay
Garnier A., Lécureux L., Sartori C., Lamy O., Griesser A.-C., 2014/05. dans European and Swiss congress of Internal Medicine 2014. Peer-reviewed.
 
Health care professionnals' attitudes towards bedside case presentations during ward rounds
Gachoud D., Garnier A., Monti M., Bart P.-A., Lamy O., Marques-Vidal P., Sartori C., Vollenweider P., Bonvin R., Villar B. et al., 2014/03., European and Swiss congress of Internal Medicine 2014 dans European and Swiss congress of Internal Medicine 2014. Peer-reviewed.
 
Calcium revisited: part II calcium supplements and their effects.
Lamy O., Burckhardt P., 2014. Bonekey Reports, 3 p. 579. Peer-reviewed.
 
Comparing Bone Microarchitecture by Trabecular Bone Score (TBS) in Caucasian American Women with and Without Osteoporotic Fractures.
Leib E., Winzenrieth R., Lamy O., Hans D., 2014. Calcified Tissue International, 95 (3) pp. 201-208. Peer-reviewed.
Discharge plan for patient with heart failure: it is worth to have a clinical pharmacist in the team
Nachar C., Voirol P., Sadeghipour F., Lamy O., Garnier A., 2014. dans European and Swiss congress of Internal Medicine 2014. Peer-reviewed.
 
Effects of Exemestane and Tamoxifen Treatment on Bone Texture Analysis Assessed by TBS in Comparison With Bone Mineral Density Assessed by DXA in Women With Breast Cancer.
Kalder M., Hans D., Kyvernitakis I., Lamy O., Bauer M., Hadji P., 2014. Journal of Clinical Densitometry, 17 (1) pp. 66-71. Peer-reviewed.
 
Fractures atypiques du fémur: A propos de trois cas cliniques [Atypical fractures of the femur: apropos of 3 clinical cases].
Sanduloviciu M., Stoll D., Lamy O., Krieg M.A., Aubry-Rozier B., 2014. Praxis, 103 (16) pp. 939-944. Peer-reviewed.
 
Lumbar spine texture enhances 10-year fracture probability assessment.
Leslie W.D., Johansson H., Kanis J.A., Lamy O., Oden A., McCloskey E.V., Hans D., 2014. Osteoporosis International, 25 (9) pp. 2271-2277. Peer-reviewed.
 
Maladies infectieuses - Pneumonie communautaire de l'adulte
Chapuis T., Pasche O., Kermode-Noppel T., Cornuz J., Lamy O., Zanetti G, 2014. pp. 255-264 dans Cornuz Jacques, Pasche Olivier (eds.) COMPAS : Stratégies de Prise en Charge Clinique : Médecine Interne Générale Ambulatoire. chap. 18, Médecine et Hygiène.
 
Morphometric Vertebral Assessments via the Use of Dual X-ray Absorptiometry for the Evaluation of Radiographic Damage in Ankylosing Spondylitis: A Pilot Study.
Aubry-Rozier B., Hans D., Krieg M.A., Lamy O., Dudler J., 2014. Journal of Clinical Densitometry, 17 (1) pp. 190-194. Peer-reviewed.
 
Risks and benefits of percutaneous vertebroplasty or kyphoplasty in the management of osteoporotic vertebral fractures.
Lamy O., Uebelhart B., Aubry-Rozier B., 2014. Osteoporosis International, 25 (3) pp. 807-819.
The role of teriparatide in sequential and combination therapy of osteoporosis.
Meier C., Lamy O., Krieg M.A., Mellinghoff H.U., Felder M., Ferrari S., Rizzoli R., 2014. Swiss Medical Weekly, 144 pp. w13952. Peer-reviewed.
 
Trabecular bone score: a noninvasive analytical method based upon the DXA image.
Silva B.C., Leslie W.D., Resch H., Lamy O., Lesnyak O., Binkley N., McCloskey E.V., Kanis J.A., Bilezikian J.P., 2014. Journal of Bone and Mineral Research, 29 (3) pp. 518-530. Peer-reviewed.
β-Lactam Monotherapy vs β-Lactam-Macrolide Combination Treatment in Moderately Severe Community-Acquired Pneumonia: A Randomized Noninferiority Trial.
Garin N., Genné D., Carballo S., Chuard C., Eich G., Hugli O., Lamy O., Nendaz M., Petignat P.A., Perneger T. et al., 2014. Jama Internal Medicine, 174 (12) pp. 1894-1901. Peer-reviewed.
 
Biomarqueurs associés à la dyspnée et douleurs thoraciques: quelle utilité clinique [Biomarkers associated with dyspnea and chest pain: which cinical utility?].
Lamy O., 2013. Revue Médicale Suisse, 9 (404) pp. 1992-1997.
Can one or two high doses of oral vitamin D3 correct insufficiency in a non-supplemented rheumatologic population?
Stoll D., Dudler J., Lamy O., Hans D., Krieg M.A., Aubry-Rozier B., 2013. Osteoporosis International, 24 (2) pp. 495-500.
Changing the awareness of low vitamin D status in a rheumatology population: a pre/post-study.
Stoll D., Lamy O., Hans D., Zufferey P., So A., Krieg M.A., Aubry-Rozier B., 2013. Swiss Medical Weekly, 143 pp. w13891.
 
Effects of zoledronate versus placebo on spine bone mineral density and microarchitecture assessed by the trabecular bone score in postmenopausal women with osteoporosis: A three-year study.
Popp A.W., Guler S., Lamy O., Senn C., Buffat H., Perrelet R., Hans D., Lippuner K., 2013. Journal of Bone and Mineral Research, 28 (3) pp. 449-454.
Severe hypercalcemia after a single high dose of vitamin D in a patient with sarcoidosis.
Hassler A., Lamy O., Rossier A., Sartori C., Gachoud D., 2013. Rheumatology International, 33 (11) pp. 2955-2956.
 
Sevrage éthylique inhabituel et compliqué: avez-vous vérifié la phosphatémie [Unusual alcoholic weaning, complicated: do you check the blood phosphate?].
Gay N., Lamy O., Pouget R., 2013. Praxis, 102 (1) pp. 49-54.
 
Stellenwert Vertebroplastie/Kyphoplastie in der Behandlung von Wirbelkörperfrakturen. [Place de la vertébroplastie et de la cyphoplastie lors de fracture vertébrale ostéoporotique.]
Lamy O., 2013. Leading Opinions. Innere Medizin, 1 pp. 20-21.
Substitution en calcium. Faut-il choisir entre l'ostéoporose et les maladies cardiovasculaires?
Lamy O., 2013. Info@gériatrie 2 pp. 19-21.
 
TBS (trabecular bone score) and diabetes-related fracture risk.
Leslie W.D., Aubry-Rozier B., Lamy O., Hans D., Manitoba Bone Density Program, 2013. Journal of Clinical Endocrinology and Metabolism, 98 (2) pp. 602-609.
What was your fracture risk evaluated by FRAX(®) the day before your osteoporotic fracture?
Aubry-Rozier B., Stoll D., Krieg M.A., Lamy O., Hans D., 2013. Clinical Rheumatology, 32 (2) pp. 219-223.
 
Wirksamkeit der medikamentösen Therapien bei unterschiedlich hohen Frakturrisko?
Lamy O., 2013. Rheuma Schweiz 1 pp. 10-14.
 
Recommendations for raloxifene use in daily clinical practice in the Swiss setting.
Lippuner K., Buchard P.A., De Geyter C., Imthurn B., Lamy O., Litschgi M., Luzuy F., Schiessl K., Stute P., Birkhäuser M., 2012/06. European Spine Journal, 21 (12) pp. 2407-2417. Peer-reviewed.
 
Améliorer la prescription d'un traitement hypolipémiant lors d'un syndrome coronarien aigu: absence de benefice d'une alerte automatique.
Genoud M., Hugli O., Rodondi N., Vogt P., Bardy D., Anex C., Dartiguenave F., Lamy. O. , 2012. pp. 58S-59S dans 80. Jahresversammlung der Schweizerischen Gesellschaft für Allgemeine Innere Medizin, Swiss Medical Forum = Forum Médical Suisse.
 
Aspects thérapeutiques de la vitamine D: quels taux cibler avec quels traitements [Therapeutic goal of vitamin D: optimal serum level and dose requirements].
Lamy O., Aubry-Rozier B., Stoll D., 2012. Revue Médicale Suisse, 8 (360) pp. 2066-2071.
 
Beneficial effects of strontium ranelate compared to alendronate on trabecular bone score in post menopausal osteoporotic women: A 2-year study
Hans D., Krieg M.A., Lamy O., Felsenberg D., 2012. pp. S266-S267 dans IOF-ECCEO 2012, 2nd European Congress on Osteoporosis and Osteoarthritis, Osteoporosis International.
 
Beneficial effects of zoledronate compared to placebo on spine bone mineral density (BMD) and microarchitecture (TBS) parameters in postmenopausal women with osteoporosis: a 3-year study
Popp A.W., Buffat H., Lamy O., Perrelet R., Hans D., Lippuner K., 2012. pp. S328 dans IOF-ECCEO 2012, 2nd European Congress on Osteoporosis and Osteoarthritis, Osteoporosis International.
 
BMD, MA estimation (TBS) and VFA extracted from a slingle DXA device in combination with CRF improve the identification of women at high risk of fracture: the OsteLaus Study.
O. Lamy O. , Krieg M.A., Metzger M., Aubry-Rozier B., Stoll D., Hans D., 2012. dans ASBMR 2012, Annual Meeting of the American Society for Bone and Mineral Research.
 
Bone mineral density (BMD), micro-architecture estimation (TBS) and vertebral fracture assessment (VFA) extracted from a single DXA device in combination with clinical risk factors improve significantly the identification of women at high risk of fracture
Lamy O., Krieg M.A., Metzger M., Aubry-Rozier B., Stoll D., Hans D., 2012. pp. A23 dans Interdisziplinärer Fachkongress OSTEOLOGIE des Dachverbandes Osteologie (DVO), Osteologie.
 
Bone mineral density (BMD), micro-architecture estimation (TBS) and vertebral fracture assessment (VFA) extracted from a single DXA device in combination with clinical risk factors improve significantly the identification of women at high risk of fracture.
Lamy O., Krieg M.A., Metzger M., Aubry-Rozier B., Stoll D., Hans D., 2012. pp. S29 dans ECTS 2012, 39th Annual Congress of the European Calcified Tissue Society, Bone.
 
Can the trabecular bone score (TBS) be considered as a major clinical risk factor (CRF) of osteoporotic fractures? A meta-like analysis
Hans D., Winzenrieth R., Aubry-Rozier B., Stoll D., Lamy O., Krieg M.A., 2012. pp. S151 dans ECTS 2012, 39th Annual Congress of the European Calcified Tissue Society, Bone.
 
Can the trabecular bone score be considered as a major clinical risk factor of osteoporotic fractures? A meta-like analysis.
Hans D., Winzenrieth R., Aubry-Rozier B., Stoll D., Lamy O., Krieg M.A., 2012. pp. A34 dans Interdisziplinärer Fachkongress OSTEOLOGIE des Dachverbandes Osteologie (DVO), Osteologie.
 
Comment améliorer la reproductibilité de lecture des VFA en dépistage clinique? la cohorte OsteoLaus.
Aubry-Rozier B., Krieg M.A., Lamy O., Hans D., Burnand B., 2012. pp. A318 dans 25e Congrès français de rhumatologie CNIT, Revue du Rhumatisme.
 
Effets bénéfiques du ranélate de strontium compare à l'alendronate sur le TBS chez les femmes ostéoporotiques ménopausées: une étude de 2 ans.
Hans D., Krieg M.A., Lamy O., Felsenberg D., 2012. pp. A238-A239 dans 25e Congrès français de Rhumatologie CNIT, Revue du Rhumatisme.
 
Evolution of Hypovitaminosis D Prevalence in a Swiss Rheumatology Outpatient Population: a pre-post Information Study
Aubry-Rozier B., Stoll D., Lamy O., Krieg M.A., Hans D., 2012. dans ASBMR 2012, Annual Meeting of the American Society for Bone and Mineral Research.
 
Faut-il traiter l'osteoporose liee a la thalassemie majeure: deux cas cliniques [Should we treat thalassemia-induced osteoporosis: two case reports].
Lucini M., Stoll D., Aubry-Rozier B., Lamy O., 2012. Praxis, 101 (20) pp. 1325-1329.
 
Fracture risk and zoledronic acid therapy in men with osteoporosis.
Boonen S., Reginster J.Y., Kaufman J.M., Lippuner K., Zanchetta J., Langdahl B., Rizzoli R., Lipschitz S., Dimai H.P., Witvrouw R. et al., 2012. New England Journal of Medicine, 367 (18) pp. 1714-1723. Peer-reviewed.
 
Fractures non traumatiques en fin de grossesse: s'agit-il toujours d'une ostéoporose? A propos de deux cas [Non-traumatic fractures at the end of a pregnancy: are there always of osteoporotic origin].
Monigel H., Stoll D., Aubry-Rozier B., Fetz G.L., Theumann N., Lamy O., 2012. Praxis, 101 (14) pp. 923-928.
 
Fractures non traumatiques liées à la grossesse et à l'allaitement : s'agit-il toujours d'une ostéoporose? A propos de 2 cas
Monigel H., Stoll D., Aubry-Rozier B., Lamy O., 2012. dans 80. Jahrestagung der Schweizerischen Gesellschaft für Allgemeine Innere Medizin.
 
FRAX in combination with microarchitecture estimation (TBS) showed the best vertebral fracture discrimination over stand-alone approaches: the OsteoLaus study
Lamy O., Krieg M. A., Stoll D., Aubry-Rozier B., Metzger M., Hans D., 2012. p. 665 dans IOF Regionals 2nd Middle East and Africa Osteoporosis Meeting / 6th Pan Arab Osteoporosis Congress (PAOC), Osteoporosis International.
 
High prevalence of osteoporosis in Swiss women aged 60 and older: a 2-year pilot screening campaign.
Krieg M.A., Lamy O., Aubry-Rozier B., Stoll D., Hans D., Berthoud M., 2012. pp. S237 dans AGS 2012, Annual Scientific Meeting of the American Geriatrics Society, Journal of the American Geriatrics Society.
 
Knochenanabole Therapie mit Teriparatid [Bone anabolic treatment with Teriparatide].
Lamy O., 2012. Therapeutische Umschau. Revue Thérapeutique, 69 (3) pp. 187-191.
 
L'ostéoporose
Lamy O., 2012. Pharmactuel / Société Suisse de Pharmacie 6 p. 37.
 
La fisioterapia respiratoria: un vantaggio per il trattamento della polmonite?: revisione Cochrane per il medico di famiglia.
Grape Sina, Fitting Jean-William, Lamy Olivier, Peytremann Bridevaux Isabelle, Barazzoni Fabrizio (Trad.), Ghirlanda Alberto (Trad.), 2012. Tribuna medica ticinese, 77 (1) pp. 25-26.
 
Learning collaboration in General Internal Medicine: a pilot project for undergraduate students in nursing, physiotherapy and medicine
Gachoud D., Layat Burn C., Kalathakis E., Bonvin R., Lamy O., 2012. pp. 53S dans 80. Jahresversammlung der Schweizerischen Gesellschaft für Allgemeine Innere Medizin, Swiss Medical Forum = Forum Médical Suisse.
 
Nouveautés dans la prise en charge des fractures vertébrales ostéoporotiques: place de la vertébroplastie et de la kyphoplastie [Trends in the treatment of spinal osteoporic fractures: vertebroplasty and kyphoplasty].
Aubry-Rozier B., Krieg M.A., Lamy O., Tonetti J., Duff J., Schizas C., Theumann N., 2012. Revue Médicale Suisse, 8 (347) pp. 1417-1421.
 
Prédiction de la fracture vertébrale: pouvoir discriminant de l'IMC, de la DMO, du TBS, du FRAX, seuls ou combinés. L'étude OsteoLaus.
Lamy O., Krieg M.A., Stoll D., Aubry-Rozier B., Metzger M., Hans D., 2012. pp. A72 dans 25e Congrès français de Rhumatologie CNIT, Revue du Rhumatisme.
 
Screening fo osteoporosis in elderly patients admitted to post-acute rehabilitation.
Major K., Monod S., Bula C., Rochat S., Lamy O., Hans D., Laszlo A., Krieg M.A., 2012. pp. S102 dans AGS 2012, Annual Scientific Meeting of the American Geriatrics Society, Journal of the American Geriatrics Society.
 
TBS (Trabecular Bone Score) is More Sensitive Than BMD to Diabetes-Related Fracture Risk
Leslie W., Aubry-Rozier B., Goertzen A., Lamy O., Hans D., 2012. dans ASBMR 2012, Annual Meeting of the American Society for Bone and Mineral Research.
TBS en routine clinique: propositions d'utilisation - L'apport de la texture osseuse dans la prise en charge des ostéoporoses
Cormier C., Lamy O., Poriau S., Aubry-Rozier B., Bernard P., Bloch J.G., Cormier C., Stoll D., Dufour R., Héraud A. et al., 2012..
 
The micro-architecture estimation by TBS discriminate women with and without osteoporotic fracture independently of age, BMI and BMD: The Osteo-Mobile Vaud cohort study.
Krieg M.A., Lamy O., Aubry-Rozier B., Stoll D., Krieg C., Berthoud M., Hans D., 2012. pp. A23-A24 dans Interdisziplinärer Fachkongress OSTEOLOGIE des Dachverbandes Osteologie (DVO), Osteologie.
 
The OsteoLaus Cohort Study Bone mineral density, micro-architecture score and vertebral fracture assessment extracted from a single DXA device in combination with clinical risk factors improve significantly the identification of women at high risk of fracture
Lamy O., Krieg M.A., Stoll D., Aubry-Rozier B., Metzger M., Hans D., 2012. Osteologie, 21 (2) pp. 77-82.
 
What should be the intervention thresholds of trabecular bone score (TBS) when used as a major clinical risk factor (CRF) of osteoporotic fractures (OPS)? A meta-like analysis
Hans Didier, Winzenrieth Renaud, Aubry-Rozier Berengere, Stoll Delphine, Lamy Olivier, Krieg Marc-Antoine, 2012. pp. S569-S570 dans Osteoporosis and Bone Conference, Osteoporosis International.
 
What should be the intervention thresholds of trabecular bone score (TBS) when used as a major clinical risk factor (CRF) of osteoporotic fractures (OPs)? A meta-like analysis
Hans Didier, Winzenrieth Renaud, Aubry-Rozier Berengere, Stoll Delphine, Lamy Olivier, Krieg Marc-Antoine, 2012. pp. S301-S302 dans IOF-ECCEO European Congress on Osteoporosis and Osteoarthritis / 2nd IOF-ESCEO Pre-Clinical Symposium, Osteoporosis International.
A single high dose of oral vitamin D3 is insufficient to correct a deficiency in a rheumatologic population
Stoll D., Lamy O., Krieg M.A., Hans D., Dudler J., So A., Aubry-Rozier B., 2011. p. 22 dans SBMS-SVGO/ASCO Joint Meeting 2011, Journal für Mineralstoffwechsel.
 
Adhésion thérapeutique et maladies chroniques: l'exemple de l'ostéoporose [Adherence and chronic disease: what's about osteoporosis].
Aubry-Rozier B., Lamy O., 2011. Revue Médicale Suisse, 7 (299) pp. 1316-1319.
 
Evaluation des facteurs de risque clinique et des données de la DXA (DMO: VFA; TBS) pour la prédiction du risque fracturaire : étude de cohorte OséoLaus
Lamy O., Krieg M.A., Metzger M., Aubry-Rozier B., Soll D., Hans D, 2011. dans 24e Congrès Français de Rhumatologie, Revue du Rhumatisme.
 
Evaluation des facteurs de risque cliniques et des données de la DXA (DMO, VFA, TBS) pour la prédiction du risque fracturaire. L'étude de la cohorte OséoLaus.
Lamy O., Krieg M.A., Metzger M., Aubry-Rozier B., Stoll D., Hans D., 2011. pp. A67 dans 24e Congrès Français de Rhumatologie, Revue du Rhumatisme.
High prevalence of hypovitaminosis D in a Swiss rheumatology outpatient population.
Stoll D., Dudler J., Lamy O., Hans D., So A., Krieg M.A., Aubry-Rozier B., 2011. Swiss Medical Weekly, 141 (w13196) pp. 1-5.
 
How High Dose(s) of Oral Vitamin D3 Can Correct Insufficiency in a Non Supplemented Rheumatologic Population ?
Lamy O., Hans D., Krieg M.A., Dudler J., Aubry-Rozier B., Stoll D., 2011. dans ASBMR 2011, Annual Meeting of the American Society for Bone and Mineral Research.
Indications to teriparatide treatment in patients with osteoporosis.
Rizzoli R., Kraenzlin M., Krieg M.A., Mellinghoff H.U., Lamy O., Lippuner K., 2011. Swiss Medical Weekly, 141 pp. w13297.
IVA in addition to BMD can change the osteoporosis management in 25% of clinical routine patients
Aubry-Rozier B., Stoll D., Krieg M.A., Lamy O., Hans D., 2011. p. 21 dans SBMS-SVGO/ASCO Joint Meeting 2011, Journal für Mineralstoffwechsel.
 
La cohorte OstéoLaus: évaluation des outils de routine clinique pour la prédiction de la fracture ostéoporotique [OsteoLaus: prediction of osteoporotic fractures by clinical risk factors and DXA, IVA and TBS].
Lamy O., Metzger M., Krieg M.A., Aubry-Rozier B., Stoll D., Hans D., 2011. Revue Médicale Suisse, 7 (315) pp. 2130, 2132-2134, 2136.
 
La physiothérapie respiratoire: un avantage pour le traitement de la pneumonie ? : revue Cochrane pour le praticien
Grape S., Fitting J.W., Lamy O., Peytremann-Bridevaux I., Burnand B., Rège Walther M., Marino L., Méan M., Merz L., Regamey J. et al., 2011. Revue Médicale Suisse, 7 (280) p. 321.
 
La sarcopénie: définition, méthodes de mesure, avenir thérapeutique [Sarcopenia: definition, methods of measurement, therapeutic future].
Rivier E., Krieg M.A., Lamy O., 2011. Revue Médicale Suisse, 7 (294) pp. 1047-1048.
 
Once-yearly zoledronic acid and days of disability, bed rest, and back pain: randomized, controlled HORIZON Pivotal Fracture Trial.
Cauley J.A., Black D., Boonen S., Cummings S.R., Mesenbrink P., Palermo L., Man Z., Hadji P., Reid I.R., HORIZON Pivotal Fracture Group, 2011. Journal of Bone and Mineral Research, 26 (5) pp. 984-992.
 
Ostéoporose: évaluation du risque fracturaire [Osteoporosis: evaluation and fracture risk].
Lamy O., Kraenzlin M., 2011. Revue Médicale Suisse, 7 (294) pp. 1018-1019.
 
Prescription d'un traitement hypolipémiant lors d'un syndrome coronarien aigu en fonction du profil lipidique
Genoud M., Hugli O., Rodondi N., Vogt P., Bardy D., Anex C., Dartiguenave F., Lamy O., 2011. pp. 55S dans 79e Assemblée Annuelle de la Société Suisse de Médecine Interne Générale, Swiss Medical Forum = Forum Medical Suisse.
 
Soll bei einer Pneumonie Atemphysiotherapie verordnet werden?: Mini-Review Cochrane für die Praxis
Grape Sina, Fitting Jean-William, Lamy Olivier, Peytremann Bridevaux Isabelle, 2011. Praxis, 100 (24) pp. 1499-1500.
 
TBS discrimine les femmes avec ostéoporose des femmes non ostéoporosiques indépendamment de la DMO, de l'âge et de l'IMC : étude de la cohorte Oséo-Mobile Vaud
Krieg M.A., Lamy O., Aubry-Rozier B., Stoll D., Krieg C., Berthoud M., Hans D., 2011. dans 24e Congrès Français de Rhumatologie, Revue du Rhumatisme.
 
TBS discrimine les femmes avec ostéoporose fracturaire des femmes non ostéoporotiques indépendamment de la DMO, de l'âge et de l'IMC : Etude de la cohorte Ostéo-Mobile Vaud
Krieg M.A., Lamy O., Aubry-Rozier B., Stoll D., Krieg C., Berthoud M., Hans D., 2011. pp. A66-A67 dans 24e Congrès Français de Rhumatologie, Revue du Rhumatisme.
 
Testostérone et os: indications et limites [Testosterone and bone: indications and limitations].
Stoll D., Puder J.J., Lamy O., 2011. Revue Médicale Suisse, 7 (299) pp. 1311-1315.
Traiter ou ne pas traiter?
Lamy O., 2011. pp. 31-32 dans SBMS-SVGO/ASCO Joint Meeting 2011, Journal für Mineralstoffwechsel.
 
Troponine : les faux positifs
Genoud M., Lamy O., Rodondi N., Vogt P., Bardy D., Anex C., Dartiguenave F., Hugli O., 2011. pp. 35S dans 79e Assemblée Annuelle de la Société Suisse de Médecine Interne Générale, Swiss Medical Forum = Forum Médical Suisse.
 
A Single High Dose of Oral Vitamin D3 Is Not Enough to Correct Insufficiency and Deficiency in a Rheumatologic Population
Stoll D., Lamy O., Krieg M.A., Hans D., Dudler J., So A., Autry-Rozier B., 2010. pp. 4S-5S dans Annual Meeting of the Swiss Society of Rheumatology, Swiss Medical Weekly. Peer-reviewed.
 
A single high dose of oral Vitamin D3 is not enough to correct insufficiency and deficiency in a rheumatologic population
Stoll D., Lamy O., Krieg M.A., Hans D., Dudler J., So A., Aubry-Rozier B., 2010. dans ASBMR 2010, 30th Annual Meeting of the American Society for Bone and Mineral Research, Journal of Bone and Mineral Research. Peer-reviewed.
 
Comparison of two osteoporotic fracture management pathways: experience at 1 year
Aubry-Rozier B., Stoll D., Hans D., So A., Krieg M.A., Lamy O., 2010. pp. 8S dans Annual Meeting of the Swiss Society of Rheumatology, Swiss Medical Weekly. Peer-reviewed.
 
Déficit en vitamine D et fractures
Basch A., Aubry-Rozier B., Krieg M.A., Lamy O., 2010. pp. 45S dans 78. Jahresversammlung der Schweizerischen Gesellschaft für Innere Medizin, Swiss Medical Forum = Forum Médical Suisse.
 
Effect of once-yearly zoledronic acid on the spine and hip as measured by quantitative computed tomography: results of the HORIZON Pivotal Fracture Trial.
Eastell R., Lang T., Boonen S., Cummings S., Delmas P.D., Cauley J.A., Horowitz Z., Kerzberg E., Bianchi G., Kendler D. et al., 2010. Osteoporosis International, 21 (7) pp. 1277-1285.
 
Facteurs de risque fracturaire, nouveaux traitements: comment evolue la prise en charge de l'ostéoporose de la personne agée [Fracture risk, new treatments: how does the management of the osteoporosis of elderly change?]
Aubry-Rozier B., Lamy O., 2010. Revue Médicale Suisse, 6 (240) pp. 569-574.
 
Faiblesse et douleurs musculaires generalisees chez une patiente de 88 ans: avez-vous pense aux medicaments [88 years old woman with acute muscular weakness and diffuse muscular pain: have you thought about the drugs?].
Arnold C.H., Lamy O., Hagmann N., 2010. Praxis, 99 (24) pp. 1507-1511.
 
Hypercalcaemia and acute renal failure after major burns: An under-diagnosed condition.
Kohut B., Rossat J., Raffoul W., Lamy O., Berger M.M., 2010. Burns : Journal of the International Society For Burn Injuries, 36 (3) pp. 360-366.
 
IVA in addition to BMD can change the osteoporosis management in 25% of clinical routine patients
Aubry-Rozier B., Stoll D., Krieg M.A., Lamy O., Hans D., 2010. pp. 5S dans Annual Meeting of the Swiss Society of Rheumatology, Swiss Medical Weekly. Peer-reviewed.
 
IVA in addition to BMD can change the osteoporosis management in 25% of clinical routine patients.
Aubry-Rozier B., Stoll D., Krieg M.A., Lamy O., Hans D., 2010. dans ASBMR 2010, 30th Annual Meeting of the American Society for Bone and Mineral Research, Journal of Bone and Mineral Research. Peer-reviewed.
 
Messages clefs du "30th American Society for Bone and Mineral Research"
Aubry-Rozier B., Lamy O., 2010. pp. 886-887 dans 30th American Society for Bone and Mineral Research, Swiss Medical Forum = Forum Médical Suisse.
 
Messages clefs du "37th European Syposium on Calcified Tissues"
Stoll D., Olivier O., 2010. pp. 534-535 dans 37th European Syposium on Calcified Tissues, Swiss Medical Forum = Forum Médical Suisse.
 
Myoclonies chez une personne très âgée; une cause fréquente et réversible [Myoclonia in an oldest old woman: a frequent and reversible etiology]
Gardiol C., Lamy O., Humbert A., 2010. Praxis, 99 (5) pp. 315-318.
 
Ostéoporose
Pasche O., de Bosset Sulzer V., Cornuz J., Lamy O., Krieg M.A., 2010. pp. 484-500 dans Cornuz J., Pasche O. (eds.) COMPAS Stratégie de prise en charge clinique en médecine interne générale ambulatoire chap. 39, Médecine et hygiène.
 
Pneumonie communautaire de l'adulte
Chapuis T., Pasche O., Cornuz J., Lamy O., Zanetti G, 2010. pp. 205-14 dans Cornuz J., Pasche O. (eds.) COMPAS Stratégie de prise en charge clinique en médecine interne générale ambulatoire chap. 15, Médecine et Hygiène.
 
Prophytaxie de l'ostéoporose cortisonique: qui, quand et quoi [Prevention of cortisone-induced osteoporosis: who, when and what?]
Aubry-Rozier B., Lamy O., Dudler J., 2010. Revue Médicale Suisse, 6 (235) pp. 307-313.
 
R6le de l'urotlogue dans le dépistage des maladies osseuses [Role of the urologist in the screening of bone diseases].
Valerio M., Lamy O., Paduch D.A., Jichlinski P., Vaucher L., 2010. Revue Médicale Suisse, 6 (274) pp. 2340-2345.
 
Tétraparésie proximale et dysautonomie: avez-vous pensé au syndrome myasthénique de Lambert-Eaton?
Pouget R., Wyder C., Lamy O., 2010. Swiss Medical Forum = Forum Médical Suisse, 10 (41) pp. 715-717.
 
Usage et utilité clinique de la CRP dans le diagnostic, le pronostic et le suivi de patients hospitalisés pour une pneumonie acquise dans la communauté. Enquête auprès des médecins du CHUV
Bauer S., Lamy O., 2010. pp. 53S dans 78. Jahresversammlung der Schweizerischen Gesellschaft für Innere Medizin, Swiss Medical Forum = Forum Médical Suisse.
 
Utilité du dosage de la CRP dans le diagnostic, le pronostic et le suivi de la pneumonie acquise dans la communauté [Role of C-reactive protein in the diagnosis, prognosis and follow-up of community-acquired pneumonia].
Bauer S., Lamy O., 2010. Revue Médicale Suisse, 6 (269) pp. 2068-70, 2072-3.
 
Vitamin d deficiency prevalence in the rheumatology population: results of a systematic screening
Stoll D., Hans D., Lamy O., Krieg M., Aubry-Rozier B., 2010. p. 73 dans IOF World Congress on Osteoporosis and 10th European Congress on Clinical and Economic Aspects of Osteoporosis and Osteoarthritis, Osteoporosis International. Peer-reviewed.
 
What was your frax (tm) the day before your hip fracture?
Aubry-Rozier B., Stoll D., Hans D., Lamy O., Krieg M., 2010. pp. 72-73 dans IOF World Congress on Osteoporosis and 10th European Congress on Clinical and Economic Aspects of Osteoporosis and Osteoarthritis, Osteoporosis International. Peer-reviewed.
 
Denosumab for prevention of fractures in postmenopausal women with osteoporosis.
Cummings S.R., San Martin J., McClung M.R., Siris E.S., Eastell R., Reid I.R., Delmas P., Zoog H.B., Austin M., Wang A. et al., 2009/11. New England Journal of Medicine, 361 (8) pp. 756-765.
Denosumab in men receiving androgen-deprivation therapy for prostate cancer.
Smith M.R., Egerdie B., Hernández Toriz N., Feldman R., Tammela T.L., Saad F., Heracek J., Szwedowski M., Ke C., Kupic A. et al., 2009/08/20. The New England journal of medicine, 361 (8) pp. 745-755.
 
Adaptation of clinical practice guidelines on major depressive disorders in the general hospital: an update.
Voellinger R., Berney A., Burnand B., Stiefel F., Depression Development Group, 2009. Journal of Psychosomatic Research, 66 (4) pp. 353-354. Peer-reviewed.
 
Déficit en vitamine D et fractures en Suisse : Lu.76
Basch A., Krieg M.A., Lamy O., Aubry-Rozier B., 2009. pp. 1073-1074 dans SFR 2009, 22e Congrès Français de Rhumatologie, Revue du Rhumatisme.
 
Effect of once-yearly zoledronic acid five milligrams on fracture risk and change in femoral neck bone mineral density.
Eastell R., Black D.M., Boonen S., Adami S., Felsenberg D., Lippuner K., Cummings S.R., Delmas P.D., Palermo L., Mesenbrink P. et al., 2009. Journal of Clinical Endocrinology and Metabolism, 94 (9) pp. 3215-3225. Peer-reviewed.
 
Have all the men and women with a fragility fracture a low bone mineral density ? A Nationwide Swiss Survey : P13
Lamy O., Zufferey P., Suhm N., Babst R., von Kempis J., Waldburger M., Lippuner K., Krieg M.A., 2009. pp. 5-6 dans 77e Assemblée Annuelle de la Société Suisse de Médecine Interne (SSMI), Swiss Medical Weeky. Peer-reviewed.
 
Have all the men and women with a fragility fracture a low bone mineral density? A Nationwide Swiss Survey : FM3
Lamy O., Suhm N., Babst R., Krieg M.A., von Kempis J., Waldburger M., Zufferey P., Lippuner K.., 2009. pp. 3S dans 77. Jahresversammlung der Schweizerischen Gesellschaft für Innere Medizin, Swiss Medical Forum = Forum Médical Suisse.
 
Indice TBS : la Microarchitecture par DXA
Hans D., Cormier C., Bloch J.G., Dufour R., Heraud A., Barthe N., Colson F., Giraldi J.M., Lamy O., Krieg M.A., 2009. Abstract Rhumatologie 302 pp. 4-8.
 
Indice TBS : la microarchitecture par DXA.
Hans D., Cormier C., Bloch J.G., Dufour R., Heraud A., Barthe N., Colson F., Giraldi J.M., Lamy O., Krieg M.A., 2009. Abstract Rhumatologie 302 pp. 1-6.
 
Osteoporotic fractures : A new collaboration with surgeons : P17
Aubry-Rozier B., Krieg M.A., Moushine E., Lamy O., 2009. pp. 6-7 dans Annual meeting of the Swiss Society of Rheumatology (SGR), Symposium Health Professionals in Rheumatology combined with the 6th Conference on Sex Hormones, Pregnancy and Rheumatic Diseases, Swiss Medical Weeky. Peer-reviewed.
 
Quel était votre FRAX? la veille de votre fracture? : O.01
Basch A., Dudler J., Krieg M.A., Lamy O., Moushine E., Aubry-Rozier B., 2009. p. 982 dans SFR 2009, 22e Congrès de la Société Française de Rhumatologie, Revue du Rhumatisme.
Management of fragility fractures in Switzerland: results of a nationwide survey.
Suhm N., Lamy O., Lippuner K., OsteoCare study group, 2008/11/15. Swiss medical weekly, 138 (45-46) pp. 674-683. Peer-reviewed.
 
Cost effectiveness and cost utility of risedronate for osteoporosis treatment and fracture prevention in women: a Swiss perspective.
Wasserfallen J.B., Krieg M.A., Greiner R.A., Lamy O., 2008. Journal of Medical Economics, 11 (3) pp. 499-523.
 
Efficacy of clinical guideline implementation to improve the appropriateness of chest physiotherapy prescription among inpatients with community-acquired pneumonia
Guessous I., Cornuz J., Stoianov R., Burnand Bernard, Fitting J.W., Yersin B., Lamy O., 2008. Respiratory medicine, 102 (9) pp. 1257-1263. Peer-reviewed.
Fracture ostéoporotique chez les femmes ménopausées: l'alendronate réduit le risque. [Osteoporotic fracture in menopausal women: alendronate reduces the risk]
Bize R., Lamy O., Peytremann-Bridevaux I., 2008. Revue Médicale Suisse, 4 (183) p. 2703.
 
Ostéoporose : comment faire des économies en traitant la personne âgée
Lamy O., 2008. Gériatrie Pratique 6 pp. 13-16.
 
De la nécessité des études coût-efficacité en ostéoporose. [The necessity of cost-effectiveness analysis in osteoporosis]
Lamy O., Krieg M. A., 2007/06. Revue Médicale Suisse, 3 (115) pp. 1521-5.
 
Der Ikterus des Herrn P. [Mr. P.'s jaundice]
Andrey V., Bacher C., Lamy O., 2007/06. Schweizerische Rundschau fur Medizin Praxis, 96 (23) pp. 935-6.
 
Abcès splénique: étiologie, diagnostic et possibilités thérapeutiques [Splenic abscess: etiology, diagnosis and possible therapeutics]
Burnier C., Ribordy-Baudat V., Lamy O., 2007. Schweizerische Rundschau fur Medizin Praxis, 96 (44) pp. 1731-1735.
 
Delirium: guidelines for general hospitals.
Michaud L., Büla C., Berney A., Camus V., Voellinger R., Stiefel F., Burnand B., Delirium Guidelines Development Group, 2007. Journal of Psychosomatic Research, 62 (3) pp. 371-383. Peer-reviewed.
 
Effet antalgique des bisphosphonates en médecine palliative : mythes et réalités
Lamy O., 2007. INFOKara 22 pp. 75-78.
 
Fracture vertébrate évaluée par ostéodensitométrie. Un nouveau facteur de risque pour la fracture [Vertebral fracture assessed by DXA: a new risk factor for fracture]
Krieg M.A., Lamy O., Hans D., 2007. Revue Médicale Suisse, 3 (115) pp. 1496-1501.
 
Insuffisance surrénalienne et hypercalcémie: association fortuite [Adrenal insufficiency and hypercalcemia--an unusual presentation]
Mihalache A., Lamy O., Waeber G., Schneider A., 2007. Praxis, 96 (45) pp. 1761-1765.
 
Once-yearly zoledronic acid for treatment of postmenopausal osteoporosis.
Black D.M., Delmas P.D., Eastell R., Reid I.R., Boonen S., Cauley J.A., Cosman F., Lakatos P., Leung P.C., Man Z. et al., 2007. New England Journal of Medicine, 356 (18) pp. 1809-1822. Peer-reviewed.
 
Peut-on évaluer te risque hémorragique tors d'anticoagutation orale [Oral anticoagulation and the risk of major bleeding]
Cosma Rochat M., Waeber G., Lamy O., Aujesky D., 2007. Revue médicale suisse, 3 (131) pp. 2461-2, 2464-5.
 
Prescrire "le lit strict" dans un service hospitalier de médecine interne: un traitement dangereux [Complete bed rest prescription in an internal medicine ward: a dangerous treatment?]
Moret C., Aujesky D., Lamy O., 2007. Revue médicale suisse, 3 (131) pp. 2479-82.
 
Une cause rare d'adénopathie cervicale [A rare cause of cervical adenopathy]
Comte D., Lamy O., Schwab M., 2007. Schweizerische Rundschau fur Medizin Praxis, 96 (46) pp. 1821-1824.
Partagez:
Unicentre - CH-1015 Lausanne
Suisse
Tél. +41 21 692 11 11
Fax. +41 21 692 26 15
Swiss University